Thank you for your interest in fulfilling your NSN requirements with ASAP Semiconductor. On this page, you can find the Levothyroxine Sodium Tablets Usp parts we carry, each being listed alongside key details like part numbers, NSNs, item names, manufacturers, CAGE Codes, and FSC data for quick identification. Take the time you need to view and compare listings, knowing that everything featured is available for purchase at any time. Should you wish to learn more about particular Levothyroxine Sodium Tablets Usp listings, do not hesitate to click on the “RFQ” button to its right to access our online quote request forms. Responses are always quick, so be sure to get started today!
Levothyroxine Sodium Tablets Usp Solutions We Currently Feature
| Part No. | NSN | Item Name | Manufacturer | CAGE Code | FSC | Availability | RFQ | |
|---|---|---|---|---|---|---|---|---|
| NDC00074-4341-90 | 6505-01-596-5291 (6505015965291) |
levothyroxine sodium tablets usp | abbott laboratories inc | 4W445 | NA | Avl | RFQ |
|
| NDC00048-1020-03 | 6505-01-351-0918 (6505013510918) |
levothyroxine sodium tablets usp | abbott laboratories inc | 60060 | NA | Avl | RFQ |
|
| NDC00048-1070-13 | 6505-01-046-0333 (6505010460333) |
levothyroxine sodium tablets usp | abbott laboratories inc | 60060 | NA | Avl | RFQ |
|
| NDC00074-4552-19 | 6505-01-290-8735 (6505012908735) |
levothyroxine sodium tablets usp | abbott laboratories inc | 4W445 | NA | Avl | RFQ |
|
| NDC00048-1130-05 | 6505-01-323-4605 (6505013234605) |
levothyroxine sodium tablets usp | abbott laboratories inc | 60060 | NA | Avl | RFQ |
|
| NDC00074-6624-90 | 6505-01-596-4435 (6505015964435) |
levothyroxine sodium tablets usp | abbott laboratories inc | 4W445 | NA | Avl | RFQ |
|
| NDC00074-6624-19 | 6505-01-042-9260 (6505010429260) |
levothyroxine sodium tablets usp | abbott laboratories inc | 4W445 | NA | Avl | RFQ |
|
| NDC00074-4552-90 | 6505-01-596-5245 (6505015965245) |
levothyroxine sodium tablets usp | abbott laboratories inc | 4W445 | NA | Avl | RFQ |
|
| NDC00048-1140-03 | 6505-00-915-1630 (6505009151630) |
levothyroxine sodium tablets usp | abbott laboratories inc | 60060 | NA | Avl | RFQ |
|
| NDC00074-4341-19 | 6505-01-099-9794 (6505010999794) |
levothyroxine sodium tablets usp | abbott laboratories inc | 4W445 | NA | Avl | RFQ |
|
| NDC00074-5182-90 | 6505-01-596-4451 (6505015964451) |
levothyroxine sodium tablets usp | abbott laboratories inc | 4W445 | NA | Avl | RFQ |
|
| NDC00048-1090-03 | 6505-01-327-0636 (6505013270636) |
levothyroxine sodium tablets usp | abbott laboratories inc | 60060 | NA | Avl | RFQ |
|
| NDC00074-7069-19 | 6505-01-153-3338 (6505011533338) |
levothyroxine sodium tablets usp | abbvie us llc | 6XMS3 | NA | Avl | RFQ |
|
| NDC00053-2545-04 | 6505-00-003-3026 (6505000033026) |
levothyroxine sodium tablets usp | armour pharmaceutical co ltd | 03884 | NA | Avl | RFQ |
|
| NDC00053-2540-06 | 6505-00-990-2021 (6505009902021) |
levothyroxine sodium tablets usp | armour pharmaceutical co ltd | 03884 | NA | Avl | RFQ |
|
| NDC00053-2541-04 | 6505-01-094-1636 (6505010941636) |
levothyroxine sodium tablets usp | armour pharmaceutical co ltd | 03884 | NA | Avl | RFQ |
|
| NDC00075-2541-02 | 6505-01-313-6243 (6505013136243) |
levothyroxine sodium tablets usp | aventis pharmaceuticals products | 04518 | NA | Avl | RFQ |
|
| 48-1140-13 | 6505-01-051-6512 (6505010516512) |
levothyroxine sodium tablets usp | baxter healthcare corporation | 04687 | NA | Avl | RFQ |
|
| 3P1163 | 6505-01-051-6516 (6505010516516) |
levothyroxine sodium tablets usp | baxter healthcare corporation | 04687 | NA | Avl | RFQ |
|
| NDC00048-1040-13 | 6505-01-055-4239 (6505010554239) |
levothyroxine sodium tablets usp | baxter healthcare corporation | 04687 | NA | Avl | RFQ |
|
| 3P1133 | 6505-01-051-6512 (6505010516512) |
levothyroxine sodium tablets usp | baxter healthcare corporation | 04687 | NA | Avl | RFQ |
|
| 3P1046 | 6505-01-051-6514 (6505010516514) |
levothyroxine sodium tablets usp | baxter healthcare corporation | 04687 | NA | Avl | RFQ |
|
| NDC00048-1090-05 | 6505-01-212-7718 (6505012127718) |
levothyroxine sodium tablets usp | baxter healthcare corporation | 04687 | NA | Avl | RFQ |
|
| 3P1063 | 6505-01-051-6513 (6505010516513) |
levothyroxine sodium tablets usp | baxter healthcare corporation | 04687 | NA | Avl | RFQ |
|
| 3P1026 | 6505-01-051-6511 (6505010516511) |
levothyroxine sodium tablets usp | baxter healthcare corporation | 04687 | NA | Avl | RFQ |
|
| 3P1176 | 6505-01-051-6515 (6505010516515) |
levothyroxine sodium tablets usp | baxter healthcare corporation | 04687 | NA | Avl | RFQ |
|
| SYNTHR0ID | 6505-00-086-1542 (6505000861542) |
levothyroxine sodium tablets usp | baxter healthcare corporation | 04687 | NA | Avl | RFQ |
|
| NDC00048-1040-05 | 6505-01-094-1636 (6505010941636) |
levothyroxine sodium tablets usp | baxter healthcare corporation | 04687 | NA | Avl | RFQ |
|
| NDC000048-1090-05 | 6505-01-027-9055 (6505010279055) |
levothyroxine sodium tablets usp | baxter healthcare corporation | 04687 | NA | Avl | RFQ |
|
| NDC00048-1090-13 | 6505-01-178-3941 (6505011783941) |
levothyroxine sodium tablets usp | baxter healthcare corporation | 04687 | NA | Avl | RFQ |
|
| SYNTHR0ID | 6505-00-227-9826 (6505002279826) |
levothyroxine sodium tablets usp | baxter healthcare corporation | 04687 | NA | Avl | RFQ |
|
| 3P1095 | 6505-01-212-7718 (6505012127718) |
levothyroxine sodium tablets usp | baxter healthcare corporation | 04687 | NA | Avl | RFQ |
|
| NDC00048-1140-05 | 6505-00-003-3026 (6505000033026) |
levothyroxine sodium tablets usp | baxter healthcare corporation | 04687 | NA | Avl | RFQ |
|
| NDC48-1070-05 | 6505-01-031-4739 (6505010314739) |
levothyroxine sodium tablets usp | baxter healthcare corporation | 04687 | NA | Avl | RFQ |
|
| NDC00048-1040-13 | 6505-01-055-4239 (6505010554239) |
levothyroxine sodium tablets usp | boots pharmaceuticals inc | 54031 | NA | Avl | RFQ |
|
| 3P1083 | 6505-01-178-3941 (6505011783941) |
levothyroxine sodium tablets usp | boots pharmaceuticals inc | 54031 | NA | Avl | RFQ |
|
| 3P1033 | 6505-01-055-4239 (6505010554239) |
levothyroxine sodium tablets usp | boots pharmaceuticals inc | 54031 | NA | Avl | RFQ |
|
| NDC00048-1070-03 | 6505-01-340-0152 (6505013400152) |
levothyroxine sodium tablets usp | boots pharmaceuticals inc | 54031 | NA | Avl | RFQ |
|
| NDC00048-1070-05 | 6505-01-042-9260 (6505010429260) |
levothyroxine sodium tablets usp | boots pharmaceuticals inc | 54031 | NA | Avl | RFQ |
|
| 3P1023 | 6505-00-990-2021 (6505009902021) |
levothyroxine sodium tablets usp | boots pharmaceuticals inc | 54031 | NA | Avl | RFQ |
|
| NDC00048-1020-03 | 6505-01-351-0918 (6505013510918) |
levothyroxine sodium tablets usp | boots pharmaceuticals inc | 54031 | NA | Avl | RFQ |
|
| NDC00048-1140-05 | 6505-01-288-4409 (6505012884409) |
levothyroxine sodium tablets usp | boots pharmaceuticals inc | 54031 | NA | Avl | RFQ |
|
| NDC00048-1080-05 | 6505-01-390-6674 (6505013906674) |
levothyroxine sodium tablets usp | boots pharmaceuticals inc | 54031 | NA | Avl | RFQ |
|
| NDC00048-1070-13 | 6505-01-046-0333 (6505010460333) |
levothyroxine sodium tablets usp | boots pharmaceuticals inc | 54031 | NA | Avl | RFQ |
|
| NDC00048-1090-13 | 6505-01-178-3941 (6505011783941) |
levothyroxine sodium tablets usp | boots pharmaceuticals inc | 54031 | NA | Avl | RFQ |
|
| NDC00048-1040-03 | 6505-01-156-1807 (6505011561807) |
levothyroxine sodium tablets usp | boots pharmaceuticals inc | 54031 | NA | Avl | RFQ |
|
| NDC00048-1080-03 | 6505-01-390-6689 (6505013906689) |
levothyroxine sodium tablets usp | boots pharmaceuticals inc | 54031 | NA | Avl | RFQ |
|
| NDC00048-1060-03 | 6505-01-390-6700 (6505013906700) |
levothyroxine sodium tablets usp | boots pharmaceuticals inc | 54031 | NA | Avl | RFQ |
|
| NDC00048-1050-03 | 6505-01-188-5387 (6505011885387) |
levothyroxine sodium tablets usp | boots pharmaceuticals inc | 54031 | NA | Avl | RFQ |
|
| NDC00048-1140-13 | 6505-01-177-1970 (6505011771970) |
levothyroxine sodium tablets usp | boots pharmaceuticals inc | 54031 | NA | Avl | RFQ |
|
| NDC00048-1100-03 | 6505-01-340-5444 (6505013405444) |
levothyroxine sodium tablets usp | boots pharmaceuticals inc | 54031 | NA | Avl | RFQ |
|
| NDC00048-1130-13 | 6505-01-390-7825 (6505013907825) |
levothyroxine sodium tablets usp | boots pharmaceuticals inc | 54031 | NA | Avl | RFQ |
|
| NDC00048-1050-05 | 6505-01-366-0962 (6505013660962) |
levothyroxine sodium tablets usp | boots pharmaceuticals inc | 54031 | NA | Avl | RFQ |
|
| NDC00048-1050-13 | 6505-01-390-7831 (6505013907831) |
levothyroxine sodium tablets usp | boots pharmaceuticals inc | 54031 | NA | Avl | RFQ |
|
| NDC00048-1130-03 | 6505-01-187-7772 (6505011877772) |
levothyroxine sodium tablets usp | boots pharmaceuticals inc | 54031 | NA | Avl | RFQ |
|
| NDC00048-1020-03 | 6505-00-990-2021 (6505009902021) |
levothyroxine sodium tablets usp | boots pharmaceuticals inc | 54031 | NA | Avl | RFQ |
|
| NDC00456-1327-01 | 6505-01-153-3222 (6505011533222) |
levothyroxine sodium tablets usp | forest pharmaceuticals inc | 65050 | NA | Avl | RFQ |
|
| NDC00456-0324-01 | 6505-01-224-9075 (6505012249075) |
levothyroxine sodium tablets usp | forest pharmaceuticals inc | 65050 | NA | Avl | RFQ |
|
| NDC00456-0321-63 | 6505-01-313-6243 (6505013136243) |
levothyroxine sodium tablets usp | forest pharmaceuticals inc | 65050 | NA | Avl | RFQ |
|
| NDC00456-0325-01 | 6505-01-134-0354 (6505011340354) |
levothyroxine sodium tablets usp | forest pharmaceuticals inc | 65050 | NA | Avl | RFQ |
|
| NDC00456-1326-01 | 6505-01-153-4435 (6505011534435) |
levothyroxine sodium tablets usp | forest pharmaceuticals inc | 65050 | NA | Avl | RFQ |
|
| NDC60846-0801-01 | 6505-01-221-3297 (6505012213297) |
levothyroxine sodium tablets usp | gemini laboratories llc | 7AN71 | NA | Avl | RFQ |
|
| NDC00182-0639-10 | 6505-00-003-3026 (6505000033026) |
levothyroxine sodium tablets usp | goldline laboratories inc | 63488 | NA | Avl | RFQ |
|
| NDC52604-5075-02 | 6505-01-366-0962 (6505013660962) |
levothyroxine sodium tablets usp | jones medical industries inc | 67071 | NA | Avl | RFQ |
|
| NDC00048-1080-05 | 6505-01-390-6674 (6505013906674) |
levothyroxine sodium tablets usp | knoll pharmaceuticals | 04477 | NA | Avl | RFQ |
|
| NDC00048-1060-03 | 6505-01-390-6700 (6505013906700) |
levothyroxine sodium tablets usp | knoll pharmaceuticals | 04477 | NA | Avl | RFQ |
|
| NDC00048-1050-13 | 6505-01-390-7831 (6505013907831) |
levothyroxine sodium tablets usp | knoll pharmaceuticals | 04477 | NA | Avl | RFQ |
|
| NDC00048-1130-03 | 6505-01-187-7772 (6505011877772) |
levothyroxine sodium tablets usp | knoll pharmaceuticals | 04477 | NA | Avl | RFQ |
|
| NDC00048-1100-03 | 6505-01-340-5444 (6505013405444) |
levothyroxine sodium tablets usp | knoll pharmaceuticals | 04477 | NA | Avl | RFQ |
|
| NDC00048-1080-03 | 6505-01-390-6689 (6505013906689) |
levothyroxine sodium tablets usp | knoll pharmaceuticals | 04477 | NA | Avl | RFQ |
|
| NDC00048-1040-03 | 6505-01-156-1807 (6505011561807) |
levothyroxine sodium tablets usp | knoll pharmaceuticals | 04477 | NA | Avl | RFQ |
|
| NDC00048-1140-13 | 6505-01-177-1970 (6505011771970) |
levothyroxine sodium tablets usp | knoll pharmaceuticals | 04477 | NA | Avl | RFQ |
|
| NDC00048-1140-05 | 6505-01-288-4409 (6505012884409) |
levothyroxine sodium tablets usp | knoll pharmaceuticals | 04477 | NA | Avl | RFQ |
|
| NDC00048-1040-13 | 6505-01-055-4239 (6505010554239) |
levothyroxine sodium tablets usp | knoll pharmaceuticals | 04477 | NA | Avl | RFQ |
|
| NDC00048-1130-13 | 6505-01-390-7825 (6505013907825) |
levothyroxine sodium tablets usp | knoll pharmaceuticals | 04477 | NA | Avl | RFQ |
|
| NDC00048-1020-03 | 6505-01-351-0918 (6505013510918) |
levothyroxine sodium tablets usp | knoll pharmaceuticals | 04477 | NA | Avl | RFQ |
|
| NDC00378-1815-10 | 6505-01-153-3338 (6505011533338) |
levothyroxine sodium tablets usp | mylan pharmaceuticals inc | 3KJG9 | NA | Avl | RFQ |
|
| NDC00378-1803-01 | 6505-01-088-4252 (6505010884252) |
levothyroxine sodium tablets usp | mylan pharmaceuticals inc | 3KJG9 | NA | Avl | RFQ |
|
| NDC00378-1817-01 | 6505-01-153-4435 (6505011534435) |
levothyroxine sodium tablets usp | mylan pharmaceuticals inc | 60895 | NA | Avl | RFQ |
|
| NDC00378-1800-01 | 6505-01-221-3297 (6505012213297) |
levothyroxine sodium tablets usp | mylan pharmaceuticals inc | 3KJG9 | NA | Avl | RFQ |
|
| NDC60793-0854-01 | 6505-01-145-8137 (6505011458137) |
levothyroxine sodium tablets usp | pfizer inc | 98377 | NA | Avl | RFQ |
|
| NDC60793-0852-01 | 6505-01-188-5387 (6505011885387) |
levothyroxine sodium tablets usp | pfizer inc | 86491 | NA | Avl | RFQ |
|
| NDC60793-0850-01 | 6505-01-221-3297 (6505012213297) |
levothyroxine sodium tablets usp | pfizer inc | 86491 | NA | Avl | RFQ |
|
| NDC60793-0851-01 | 6505-01-088-4252 (6505010884252) |
levothyroxine sodium tablets usp | pfizer inc | 86491 | NA | Avl | RFQ |
|
| NDC00536-4380-10 | 6505-01-287-0622 (6505012870622) |
levothyroxine sodium tablets usp | rugby group inc | 4V824 | NA | Avl | RFQ |
|
| NDC00536-3953-10 | 6505-01-287-0622 (6505012870622) |
levothyroxine sodium tablets usp | rugby group inc | 4V824 | NA | Avl | RFQ |
|
| 0039530 | 6505-01-287-0622 (6505012870622) |
levothyroxine sodium tablets usp | rugby group inc | 4V824 | NA | Avl | RFQ |
|
| NDC00781-5187-10 | 6505-01-153-3338 (6505011533338) |
levothyroxine sodium tablets usp | sandoz inc | 0THL4 | NA | Avl | RFQ |
|
| NDC00364-0650-02 | 6505-01-223-0961 (6505012230961) |
levothyroxine sodium tablets usp | schein henry inc | 64682 | NA | Avl | RFQ |
|
| NDC00075-2548-06 | 6505-01-224-9075 (6505012249075) |
levothyroxine sodium tablets usp | usv pharmaceutical corp | 04689 | NA | Avl | RFQ |
|
| NDC00527-1350-01 | 6505-01-153-4435 (6505011534435) |
levothyroxine sodium tablets usp | wallack william c | 6FK78 | NA | Avl | RFQ |
|
We hope that you will visit us again the next time you need board-level components, aviation and aerospace parts, and more. Allow us to serve as your strategic purchasing partner.
Request for Quote
